Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)

China · Delayed Price · Currency is CNY

81.70

-1.29 (-1.55%)

Sep 12, 2025, 3:00 PM CST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Recombinant Protein Drugs, Health Consulting and Medical Services	2.82B	Log In	Log In	Log In	Log In	Upgrade
Recombinant Protein Drugs, Health Consulting and Medical Services Growth	34.13%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
China	2.81B	Log In	Log In	Log In	Log In	Upgrade
China Growth	34.34%	Log In	Log In	Log In	Log In	Upgrade
Overseas	3.66M	Log In	Log In	Log In	Log In	Upgrade
Overseas Growth	-8.82%	Log In	Log In	Log In	Log In	Upgrade